SRI International Secures DARPA Funds to Develop Therapeutic Molecule Production Tool
SRI International has received a $4.3M grant from the Defense Advanced Research Projects Agency to develop and demonstrate a tool for manufacturing small molecules as a therapeutic option in biological threat and pandemic response efforts.